Latest Cystic fibrosis Stories
StratAcuity, The Science of People: StratAcuity successfully completes the search for the Proteostasis Therapeutics Inaugural Cystic Fibrosis Clinical Advisory Board. Boston,
CAMBRIDGE, England, and MECHELEN, Belgium, October 27, 2014 /PRNewswire/ -- GBP2.4 million grant awarded by Innovate UK, the UK's innovation agency
HAMILTON, N.J., Oct.
NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct.
SAN DIEGO, Oct.
AUSTIN, Texas, Oct. 9, 2014 /PRNewswire/ -- International Biophysics Corporation of Austin, Texas announces its filing of U.S. patent protection for its revolutionary AffloVest®.
Collaborative Forum to Focus on Promising Advances in Drug Development, Research and Care for People with CF ATLANTA, Oct.
ChanTest’s expertise will be showcased at the North American Cystic Fibrosis Conference this month, highlighting the important research the company has conducted to help move cystic fibrosis
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
NEW YORK, Oct.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- A gift; a largess; a gratuity; a present; a dole.